Pfizer's Global Gene Therapy Business: The Story So Far
Pfizer announced its entry into the gene therapy space in December 2014, when it signed a deal with Spark Therapeutics for hemophilia B. Scrip takes a look at progress to date.
Pfizer announced its entry into the gene therapy space in December 2014, when it signed a deal with Spark Therapeutics for hemophilia B. Scrip takes a look at progress to date.